Uveitis risk factors: Difference between revisions

Jump to navigation Jump to search
Line 16: Line 16:
'''Acute anterior uveitis''': [[HLA-B27]] [[allele]], [[ankylosing spondylitis]], [[psoraitic arthritis]]<br>
'''Acute anterior uveitis''': [[HLA-B27]] [[allele]], [[ankylosing spondylitis]], [[psoraitic arthritis]]<br>
'''TINU syndrome''': Female gender<br>
'''TINU syndrome''': Female gender<br>
'''[[Vogt-Koyanagi-Harada disease]]: Hispanic or Japanese race, [[HLA-DR1]] and [[HLA-DR4]] [[alleles]]<br>
'''[[Vogt-Koyanagi-Harada disease]]''': Hispanic or Japanese race, [[HLA-DR1]] and [[HLA-DR4]] [[alleles]]<br>
'''Drug-induced uveitis''': Use of [[rifabutin]], [[cidofovir]], [[bisphosphonates]], [[sulfonamides]], [[moxifloxacin]], [[metipranolol]], [[brimonidine]], [[prostaglandin]] analogues, [[flurbiprofen]]
'''Drug-induced uveitis''': Use of [[rifabutin]], [[cidofovir]], [[bisphosphonates]], [[sulfonamides]], [[moxifloxacin]], [[metipranolol]], [[brimonidine]], [[prostaglandin]] analogues, [[flurbiprofen]]



Revision as of 15:57, 29 July 2016

Uveitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Uveitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Uveitis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Uveitis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Uveitis risk factors

CDC on Uveitis risk factors

Uveitis risk factors in the news

Blogs on Uveitis risk factors

Directions to Hospitals Treating Uveitis

Risk calculators and risk factors for Uveitis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Tarek Nafee, M.D. [2]

Overview

There are no established risk factors for most etiologies of uveitis. Some underlying causes have potent risk factors for developing uveitis.

Risk factors

There are no established risk factors for most etiologies of uveitis. Some underlying causes may have potent risk factors for developing uveitis such as:
Acute posterior multifocal placoid pigment epitheliopathy: HLA-B27 or HLA-DR2 alleles, preceding viral illness, underlying vasculitis
CMV retinitis: HIV, CD4 count <50, severe immunosuppression, localized ocular immunosuppression
Necrotizing herpitic retinitis: Immunosuppression
Punctuate inner choroidopathy: Myopia in females, age 18 to 40
Sarcoid uveitis: African American race, age<50
Autoimmune scleritis: Female gender, age 40-60 years
Sympathetic ophthalmia: ocular trauma with delayed closing of the wound
Acute anterior uveitis: HLA-B27 allele, ankylosing spondylitis, psoraitic arthritis
TINU syndrome: Female gender
Vogt-Koyanagi-Harada disease: Hispanic or Japanese race, HLA-DR1 and HLA-DR4 alleles
Drug-induced uveitis: Use of rifabutin, cidofovir, bisphosphonates, sulfonamides, moxifloxacin, metipranolol, brimonidine, prostaglandin analogues, flurbiprofen

References

Template:WH Template:WS